Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non‐relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA‐matched sibling donors

Abstract

High dose of NK cells may play an important role in improving transplant outcomes, in terms of reducing NRM and infectious events together with CD34+ cells.